Medical device therapeutic expertise is everything
Innovating in MedTech means recognizing the unique demands of each therapeutic area and applying the right expertise to meet them.
Purpose built for MedTech. Because your challenges are unique.
MedTech innovation operates in a fast‑changing regulatory environment. Our MedTech‑focused teams are purpose‑built to work within this complexity, bringing device‑specific perspective from development through global commercialization.
We help you make sense of regulatory change, anticipate constraints, and reduce friction that can delay approval or limit market access. By tailoring strategy to your device type, technology, and intended markets, we help innovators move forward with greater clarity— advancing development to supporting long‑term impact
Specialization matters. We deliver more relevant guidance, fewer surprises, and a clearer path to value creation across medical devices, in vitro diagnostics (IVD), digital health, and combination products. Explore our specialty areas below.
Medical Device Consulting
Medical device innovators face increasing regulatory complexity, regional variation, and pressure to move faster without compromising quality or safety. IQVIA MedTech helps innovators navigate evolving global requirements—from development through commercialization—reducing friction that can slow approval or limit market access.
We tailor strategy to your device type, intended use, risk classification, and target markets, drawing on deep regulatory and development experience across global pathways. Our experience spans a broad range of medical devices, including surgical instruments and platforms, implantable and interventional devices, and diagnostic and imaging hardware.
In Vitro Diagnostic Devices (IVD) Consulting
Diagnostic innovators must manage evolving requirements, diverse intended uses, and global scale—often while balancing speed, scientific rigor, and long-term commercial success. IQVIA MedTech helps innovators navigate that complexity with a single, integrated partner guiding them from concept through commercialization. Our experts—including former FDA and Notified Body reviewers—support manufacturers across all IVD intended uses such as Laboratory Developed Tests (LDTs) and Companion Diagnostics (CDx).
Backed by decades of IVD experience and deep global intelligence, IQVIA MedTech provides the insight and execution support innovators need to plan confidently, prepare for submissions, and scale diagnostics across markets and therapy areas including laboratory systems, point-of-care testing, liquid biopsy, and more.
Digital Health Consulting
Digital health innovators face growing scrutiny around validation, transparency, cybersecurity, and lifecycle change, often while regulatory guidance continues to evolve. IQVIA MedTech helps teams translate these shifting digital health and AI requirements into clear, practical pathways. We support software as a medical device (SaMD), AI enabled technologies, connected sensors, imaging software and more, by connecting development strategy with clinical evidence, quality systems, and algorithm validation —from early planning through submission, launch, and post market monitoring.
By integrating digital health expertise with advanced analytics and real-world data, we help innovators build safe, effective technologies designed to scale, adapt, and perform over time.
Biologics & Combination Products Consulting
Biologic and combination product innovators face distinct challenges at the intersection of device engineering, biologic science, manufacturing complexity, and clinical evidence generation. Navigating these pathways requires deep specialization and an integrated understanding of how biologics and devices evolve together.
IQVIA MedTech supports a broad range of combination products, drawing on decades of experience advancing technologies from early concept through market authorization and use. Our expertise spans regenerative medicine, point of care biologic processing systems, drug delivery platforms, tissue engineering solutions, and HCT/P related products.
By connecting scientific understanding with development, clinical, and commercialization insight, IQVIA MedTech helps innovators manage complexity, make informed decisions, and advance biologic and combination technologies
Built to help MedTech innovation thrive
Providing clarity and device‑centric insight in all phases of innovation.
FAQ
IQVIA MedTech provides specialized consulting and development support for biologics and combination products. Their teams work across device engineering, biologic science, and clinical strategy to help manufacturers navigate complex development pathways—from early concept through pre-market development and market authorization. This includes support for regenerative medicine, drug-delivery platforms, tissue engineering technologies, and point-of-care biologic systems.
IQVIA MedTech supports in vitro diagnostic (IVD) manufacturers with end-to-end services, from concept through commercialization. Their experts guide companies across diverse intended uses—including companion diagnostics (CDx) and laboratory-developed tests (LDTs)—helping plan regulatory strategies, prepare submissions, and scale diagnostics across global markets.
IQVIA MedTech helps digital health and AI-enabled MedTech companies translate evolving regulatory expectations into clear development pathways. This includes support for software as a medical device (SaMD), connected devices, and imaging software—covering validation, cybersecurity, and lifecycle management.